Charles Shuler to Receive the 2016 IADR Distinguished Scientist Award in Oral Medicine & Pathology

FOR IMMEDIATE RELEASE                                                                   

IADR contact: Ingrid L. Thomas
+1.703.548.0066 or
ithomas@iadr.org

June 21, 2016                                                                                                                

Alexandria, Va., USA - The International Association for Dental Research (IADR) will present Charles Shuler with the 2016 IADR Distinguished Scientist Award in Oral Medicine and Pathology. He will be recognized at the Opening Ceremonies of the 94th IADR General Session & Exhibition, Wednesday, June 22, 2016, in Seoul, Republic of Korea. This meeting will be held in conjunction with the 3rd Meeting of the IADR Asia Pacific Region and the 35th Annual Meeting of the IADR Korean Division.

Shuler is a professor and dean of the Faculty of Dentistry, University of British Columbia, Vancouver, Canada. He earned his B.S. in biochemistry at the University of Wisconsin – Madison, USA, and his D.M.D. from Harvard University School of Dental Medicine, Boston, Mass., USA. He completed his oral pathology residency at the University of Minnesota, Minneapolis, USA, and earned his Ph.D. in pathology from the University of Chicago, Ill., USA.

Shuler has conducted outstanding and sustained peer-reviewed research in three major areas: 1) development of the secondary palate; 2) characterization of molecular changes in oral cancer; and 3) characterization of the role of microbial biofilms in bisphosphonate related osteonecrosis of the jaws. For nearly 30 years, the primary research focus of Shuler’s laboratory has been investigations of the control of fusion of the secondary palate. These studies have examined the medial edge epithelium (MEE) of the palatal shelves. He and a team of scientists in his lab identified the critical role of TGF-β3 in the process of palatal fusion and the expression of that molecule in the MEE. Their findings of the critical role of TGF-β3 in palatal fusion have been translated into clinical applications screening pregnant women and it has been shown that some isoforms of TGF-β3 are associated with increased incidence of cleft lip/palate in humans when the mother smokes while pregnant. Their studies continue to examine the mechanism of TGF-β3 during palatogenesis to identify specific targets for teratogenic molecules that are linked with craniofacial birth defects. Additionally, he has been involved in education research and several clinical research projects.

One of the 17 IADR Distinguished Scientist Awards, the Oral Medicine & Pathology Research Award is one of the highest honors bestowed by IADR. The Award is supported by Unilever Oral Care and recognizes outstanding and sustained peer-reviewed research that has contributed to the understanding of the mechanisms governing the health and disease of the oral cavity and associated structures, principally encompassing skin, bone and the oral soft tissue. The award consists of a monetary prize and a plaque.

About the International and American Associations for Dental Research
The International Association for Dental Research (IADR) is a nonprofit organization with nearly 10,500 individual members worldwide, dedicated to: (1) advancing research and increasing knowledge for the improvement of oral health worldwide, (2) supporting and representing the oral health research community, and (3) facilitating the communication and application of research findings. To learn more, visit www.iadr.org.

Username
Password

Related Content

2015 Annual Report

Learn More »